Panel Discussion: How to Monitor and Minimize Variation and Mistakes (Clinical Chemistry Forum) (Discussion)
Clinical Chemistry 1997, May, 43, 5
-
- $5.99
-
- $5.99
Publisher Description
Panel II of the 1996 Clinical Chemistry Forum was a discussion initiated by brief formal presentations from Rosemary Bakes-Martin of the US Centers for Disease Control and Prevention (CDC), Cornelia Rooks of the US Food and Drug Administration (FDA), William Hamlin of the College of American Pathologists (CAP), Nathan Gochman of Beckman Instruments, and David Witte of this Forum Committee. Initial Presentations
GENRE
Science & Nature
RELEASED
1997
May 1
LANGUAGE
EN
English
LENGTH
19
Pages
PUBLISHER
American Association for Clinical Chemistry, Inc.
SELLER
The Gale Group, Inc., a Delaware corporation and an affiliate of Cengage Learning, Inc.
SIZE
192.5
KB
More Books Like This
Quality: The Next Six Months (Clinical Chemistry Forum)
1997
Analytical Performance Characteristics should be Judged Against Objective Quality Specifications (Editorial)
1999
Quality Assurance
2013
Laboratory Medicine: Challenges and Opportunities (Opinion)
2007
Pharmaceutical Analysis for Small Molecules
2017
Pharmaceutical Quality by Design
2018
More Books by Clinical Chemistry
Doping in Sport: Misuse, Analytical Tests, And Legal Aspects (Editorial)
1997
Vitamin E and Coronary Heart Disease in Tunisians (Nutrition) (Clinical Report)
2000
Endothelial Nitric Oxide Synthase Haplotypes Are Associated with Features of Metabolic Syndrome (Endocrinology and Metabolism) (Survey)
2007
T-Cell Regulatory Gene CTLA-4 Polymorphism/Haplotype Association with Autoimmune Pancreatitis (Clinical Immunology)
2007
Percent Free Prostate-Specific Antigen in Assessing the Probability of Prostate Cancer Under Optimal Analytical Conditions (Enzymes and Protein Markers)
1998
High-Throughput Genotyping of Oncogenic Human Papilloma Viruses with MALDI-TOF Mass Spectrometry (Molecular Diagnostics and Genetics)
2008